How Shkreli turned $2M into $1B in pharma, the Daraprim story, prison, and what comes next.
Watch →Martin's own show — markets, medicine, biotech, and unfiltered commentary. New episodes regularly.
Watch →Hours of pharmaceutical breakdowns, market analysis, and unfiltered commentary.
Watch →Shkreli on his prosecution, the media narrative, and pharmaceutical innovation.
Watch →Regular X Spaces appearances discussing biotech, politics, and current events.
Follow →Post-release interview on pharmaceutical pricing, innovation, and the future of drug development.
Read →